Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? / Trifirò, Gianluca; Crisafulli, Salvatore; Andò, Giuseppe; Racagni, Giorgio; Drago, Filippo; Taglialatela, Maurizio. - In: DRUG SAFETY - CASE REPORTS. - ISSN 2198-977X. - 43:6(2020). [10.1007/s40264-020-00935-2]

Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?

Taglialatela, Maurizio
2020

2020
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? / Trifirò, Gianluca; Crisafulli, Salvatore; Andò, Giuseppe; Racagni, Giorgio; Drago, Filippo; Taglialatela, Maurizio. - In: DRUG SAFETY - CASE REPORTS. - ISSN 2198-977X. - 43:6(2020). [10.1007/s40264-020-00935-2]
File in questo prodotto:
File Dimensione Formato  
s40264-020-00935-2.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 562.71 kB
Formato Adobe PDF
562.71 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/992932
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 19
social impact